Literature DB >> 29352404

Mechanisms Linking Obesity and Thyroid Cancer Development and Progression in Mouse Models.

Won Gu Kim1,2, Sheue-Yann Cheng3.   

Abstract

Recent compelling epidemiological studies indicate a strong association of obesity with thyroid cancer. Obesity has been shown to promote thyroid cancer progression and exacerbate poor outcome in thyroid cancer patients. However, the molecular mechanisms by which obesity increases thyroid cancer risk and facilitates cancer progression are not completely understood. Obesity induces complex pathological changes including hyperglycemia, hyperinsulinemia, hyperlipidemia, oxidative stress, adipokines, and inflammatory responses. These changes can affect the development and progression of cancer through highly complex interactions in vivo. The deleterious effect of obesity may differ according to the different cancer types. In view of the increased incidence of thyroid cancer in parallel with the widespread occurrence of obesity in the past decades, it is imperative to clarify how obesity affects thyroid carcinogenesis. This review focuses on molecular mechanisms by which obesity aggravates thyroid carcinogenesis as elucidated by mouse models of thyroid cancer.

Entities:  

Mesh:

Year:  2018        PMID: 29352404     DOI: 10.1007/s12672-017-0320-7

Source DB:  PubMed          Journal:  Horm Cancer        ISSN: 1868-8497            Impact factor:   3.869


  59 in total

1.  Aberrant sonic hedgehog signaling pathway and STAT3 activation in papillary thyroid cancer.

Authors:  Wenwu Dong; Junshuai Cui; Xinshuai Tian; Liang He; Zhihong Wang; Ping Zhang; Hao Zhang
Journal:  Int J Clin Exp Med       Date:  2014-07-15

Review 2.  The changing incidence of thyroid cancer.

Authors:  Cari M Kitahara; Julie A Sosa
Journal:  Nat Rev Endocrinol       Date:  2016-07-15       Impact factor: 43.330

3.  Metformin inhibits thyroid cancer cell growth, migration, and EMT through the mTOR pathway.

Authors:  Baiyu Han; Hanzhi Cui; Lei Kang; Xuelin Zhang; Zhitao Jin; Lanmin Lu; Zhongyi Fan
Journal:  Tumour Biol       Date:  2015-04-09

4.  Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers.

Authors:  Iñigo Landa; Tihana Ibrahimpasic; Laura Boucai; Rileen Sinha; Jeffrey A Knauf; Ronak H Shah; Snjezana Dogan; Julio C Ricarte-Filho; Gnana P Krishnamoorthy; Bin Xu; Nikolaus Schultz; Michael F Berger; Chris Sander; Barry S Taylor; Ronald Ghossein; Ian Ganly; James A Fagin
Journal:  J Clin Invest       Date:  2016-02-15       Impact factor: 14.808

5.  Increasing incidence of differentiated thyroid cancer in the United States, 1988-2005.

Authors:  Amy Y Chen; Ahmedin Jemal; Elizabeth M Ward
Journal:  Cancer       Date:  2009-08-15       Impact factor: 6.860

6.  Bromodomain and Extraterminal Protein Inhibitor JQ1 Suppresses Thyroid Tumor Growth in a Mouse Model.

Authors:  Xuguang Zhu; Keisuke Enomoto; Li Zhao; Yuelin J Zhu; Mark C Willingham; Paul Meltzer; Jun Qi; Sheue-Yann Cheng
Journal:  Clin Cancer Res       Date:  2016-07-20       Impact factor: 12.531

7.  Metformin inhibits mammalian target of rapamycin-dependent translation initiation in breast cancer cells.

Authors:  Ryan J O Dowling; Mahvash Zakikhani; I George Fantus; Michael Pollak; Nahum Sonenberg
Journal:  Cancer Res       Date:  2007-11-15       Impact factor: 12.701

8.  The incidence of papillary thyroid carcinoma and outcomes in operative patients according to their body mass indices.

Authors:  Christophe Trésallet; Marie Seman; Frédérique Tissier; Camille Buffet; Renato Micelli Lupinacci; Hélène Vuarnesson; Laurence Leenhardt; Fabrice Menegaux
Journal:  Surgery       Date:  2014-05-27       Impact factor: 3.982

9.  Metformin Is Associated with a Favorable Outcome in Diabetic Patients with Cervical Lymph Node Metastasis of Differentiated Thyroid Cancer.

Authors:  Eun Kyung Jang; Won Gu Kim; Hyemi Kwon; Yun Mi Choi; Min Ji Jeon; Tae Yong Kim; Young Kee Shong; Won Bae Kim; Eui Young Kim
Journal:  Eur Thyroid J       Date:  2015-08-20

10.  Phase I study of OPB-51602, an oral inhibitor of signal transducer and activator of transcription 3, in patients with relapsed/refractory hematological malignancies.

Authors:  Michinori Ogura; Toshiki Uchida; Yasuhito Terui; Fumihiko Hayakawa; Yukio Kobayashi; Masafumi Taniwaki; Yasushi Takamatsu; Tomoki Naoe; Kensei Tobinai; Wataru Munakata; Takeshi Yamauchi; Akiko Kageyama; Miyuki Yuasa; Masaaki Motoyama; Takeshi Tsunoda; Kiyohiko Hatake
Journal:  Cancer Sci       Date:  2015-05-25       Impact factor: 6.716

View more
  12 in total

1.  Esophagogastric Neoplasms Following Bariatric Surgery: an Updated Systematic Review.

Authors:  Mario Musella; Giovanna Berardi; Alessio Bocchetti; Roberta Green; Valeria Cantoni; Nunzio Velotti; Katia Di Lauro; Domenico Manzolillo; Antonio Vitiello; Marco Milone; Giovanni Domenico De Palma
Journal:  Obes Surg       Date:  2019-08       Impact factor: 4.129

2.  Thyroid Receptor Antagonism of Chemicals Extracted from Personal Silicone Wristbands within a Papillary Thyroid Cancer Pilot Study.

Authors:  Christopher D Kassotis; Nicholas J Herkert; Stephanie C Hammel; Kate Hoffman; Qianyi Xia; Seth W Kullman; Julie Ann Sosa; Heather M Stapleton
Journal:  Environ Sci Technol       Date:  2020-11-13       Impact factor: 9.028

Review 3.  Review of Factors Contributing to Nodular Goiter and Thyroid Carcinoma.

Authors:  Ilgin Yildirim Simsir; Sevki Cetinkalp; Taylan Kabalak
Journal:  Med Princ Pract       Date:  2019-09-23       Impact factor: 1.927

Review 4.  Morbid Obesity and Thyroid Cancer Rate. A Review of Literature.

Authors:  Stefania Masone; Nunzio Velotti; Silvia Savastano; Emanuele Filice; Rossana Serao; Antonio Vitiello; Giovanna Berardi; Vincenzo Schiavone; Mario Musella
Journal:  J Clin Med       Date:  2021-04-27       Impact factor: 4.241

5.  Serum Adiponectin and Progranulin Level in Patients with Benign Thyroid Nodule or Papillary Thyroid Cancer.

Authors:  Hyemi Kwon; Se Eun Park; Ji-Sup Yun; Cheol-Young Park
Journal:  Endocrinol Metab (Seoul)       Date:  2020-06-24

6.  Association of Serum Progranulin Levels with Progression of Papillary Thyroid Cancer.

Authors:  Won Gu Kim
Journal:  Endocrinol Metab (Seoul)       Date:  2020-06-24

7.  Impact of Overweight and Obesity on US Papillary Thyroid Cancer Incidence Trends (1995-2015).

Authors:  Cari M Kitahara; Ruth M Pfeiffer; Julie A Sosa; Meredith S Shiels
Journal:  J Natl Cancer Inst       Date:  2020-08-01       Impact factor: 13.506

8.  Evaluation of the relationship between previous statin use and thyroid cancer using Korean National Health Insurance Service-Health Screening Cohort data.

Authors:  So Young Kim; Young Shin Song; Jee Hye Wee; Chanyang Min; Dae Myoung Yoo; Chang-Ho Lee; Chang Myeon Song; Bumjung Park; Hyo Geun Choi
Journal:  Sci Rep       Date:  2021-04-12       Impact factor: 4.379

9.  Obesity is positively related and tobacco smoking and alcohol consumption are negatively related to an increased risk of thyroid cancer.

Authors:  Soo-Youn An; So Young Kim; Dong Jun Oh; Chanyang Min; Songyoung Sim; Hyo Geun Choi
Journal:  Sci Rep       Date:  2020-11-06       Impact factor: 4.379

10.  Liver X Receptor β Related to Tumor Progression and Ribosome Gene Expression in Papillary Thyroid Cancer.

Authors:  Seonhyang Jeong; In-Kyu Kim; Hyunji Kim; Moon Jung Choi; Jandee Lee; Young Suk Jo
Journal:  Endocrinol Metab (Seoul)       Date:  2020-08-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.